Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study.

Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on... To evaluate the economic and clinical impact of infection with extended-spectrum beta -lactamase (ESBL)-producing Escherichia coli and Klebsiella species (ESBL-EK). http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Infection control and hospital epidemiology Pubmed

Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study.

Infection control and hospital epidemiology , Volume 27 (11): -1193 – Feb 15, 2007

Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study.


Abstract

To evaluate the economic and clinical impact of infection with extended-spectrum beta -lactamase (ESBL)-producing Escherichia coli and Klebsiella species (ESBL-EK).

Loading next page...
 
/lp/pubmed/impact-of-extended-spectrum-beta-lactamase-producing-escherichia-coli-4E4OjU908R

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0899-823X
DOI
10.1086/507962
pmid
17080381

Abstract

To evaluate the economic and clinical impact of infection with extended-spectrum beta -lactamase (ESBL)-producing Escherichia coli and Klebsiella species (ESBL-EK).

Journal

Infection control and hospital epidemiologyPubmed

Published: Feb 15, 2007

There are no references for this article.